Iowa General Assembly Banner


Text: SSB00170                          Text: SSB00172
Text: SSB00100 - SSB00199               Text: SSB Index
Bills and Amendments: General Index     Bill History: General Index



Senate Study Bill 171

Bill Text

PAG LIN
  1  1    Section 1.  Section 155A.4, subsection 2, Code 1997, is
  1  2 amended by adding the following new paragraph:
  1  3    NEW PARAGRAPH.  g.  A qualified individual authorized to
  1  4 administer prescription drugs and employed by a home health
  1  5 agency or hospice to obtain, possess, and transport emergency
  1  6 prescription drugs as provided by state or federal law or by
  1  7 rules of the board.
  1  8    Sec. 2.  Section 155A.15, subsection 2, paragraph d,
  1  9 unnumbered paragraph 2, Code 1997, is amended to read as
  1 10 follows:
  1 11    However, this chapter does not prohibit a pharmacy from
  1 12 furnishing a prescription drug or device to a licensed health
  1 13 care facility for storage in a secured emergency
  1 14 pharmaceutical supplies container containers maintained within
  1 15 the facility in accordance with rules of the department of
  1 16 inspections and appeals and rules of the board.
  1 17    Sec. 3.  Section 155A.27, subsection 1, unnumbered
  1 18 paragraph 1, Code 1997, is amended to read as follows:
  1 19    If written or electronic, shall contain:
  1 20    Sec. 4.  Section 155A.27, subsection 1, paragraphs d and e,
  1 21 Code 1997, are amended to read as follows:
  1 22    d.  The directions for use and the purpose of the drug,
  1 23 medicine, or device prescribed.
  1 24    e.  The name, address, and written or electronic signature
  1 25 of the practitioner issuing the prescription.
  1 26    Sec. 5.  NEW SECTION.  155A.39  PROGRAMS TO AID IMPAIRED
  1 27 PHARMACISTS, PHARMACIST INTERNS, OR PHARMACY TECHNICIANS –
  1 28 REPORTING, CONFIDENTIALITY, IMMUNITY, FUNDING.
  1 29    1.  A person or pharmaceutical peer review committee may
  1 30 report relevant facts to the board relating to the acts of a
  1 31 pharmacist in this state, a pharmacist intern as defined in
  1 32 section 155A.3, subsection 23, or a pharmacy technician in
  1 33 this state if the person or peer review committee has
  1 34 knowledge relating to the pharmacist, pharmacist intern, or
  1 35 pharmacy technician which, in the opinion of the person or
  2  1 pharmaceutical peer review committee, might impair competency
  2  2 due to chemical abuse, chemical dependence, or mental or
  2  3 physical illness, or which might endanger the public health
  2  4 and safety, or which provide grounds for disciplinary action
  2  5 as specified in this chapter and in the rules of the board.
  2  6    2.  A committee of a professional pharmaceutical
  2  7 organization, its staff, or a district or local intervenor
  2  8 participating in a program established to aid pharmacists,
  2  9 pharmacist interns, or pharmacy technicians impaired by
  2 10 chemical abuse, chemical dependence, or mental or physical
  2 11 illness may report in writing to the board the name of the
  2 12 impaired pharmacist, pharmacist intern, or pharmacy technician
  2 13 together with pertinent information relating to the
  2 14 impairment.  The board may report to a committee of a
  2 15 professional pharmaceutical organization or the organization's
  2 16 designated staff information which the board receives with
  2 17 regard to a pharmacist, pharmacist intern, or pharmacy
  2 18 technician who may be impaired by chemical abuse, chemical
  2 19 dependence, or mental or physical illness.
  2 20    3.  Upon determination by the board that a report submitted
  2 21 by a peer review committee or a professional pharmaceutical
  2 22 organization committee is without merit, the report shall be
  2 23 expunged from the pharmacist's, pharmacist intern's, or
  2 24 pharmacy technician's individual record in the board's office.
  2 25 A pharmacist, pharmacist intern, pharmacy technician, or an
  2 26 authorized representative of the pharmacist, pharmacist
  2 27 intern, or pharmacy technician shall be entitled on request to
  2 28 examine the peer review committee report or the pharmaceutical
  2 29 organization committee report submitted to the board and to
  2 30 place into the record a statement of reasonable length of the
  2 31 pharmacist's, pharmacist intern's, or pharmacy technician's
  2 32 view with respect to any information existing in the report.
  2 33    4.  Notwithstanding other provisions of the Code, the
  2 34 records and proceedings of the board, its authorized agents, a
  2 35 peer review committee, or a pharmaceutical organization
  3  1 committee as set out in subsections 1 and 2 shall be
  3  2 privileged and confidential and shall not be considered public
  3  3 records or open records unless the affected pharmacist,
  3  4 pharmacist intern, or pharmacy technician so requests and
  3  5 shall not be subject to a subpoena or to a discovery
  3  6 proceeding.  The board may disclose the records and
  3  7 proceedings only as follows:
  3  8    a.  In a criminal proceeding.
  3  9    b.  In a disciplinary hearing before the board or in a
  3 10 subsequent trial or appeal of a board action or order.
  3 11    c.  To the pharmacist licensing or disciplinary authorities
  3 12 of other jurisdictions.
  3 13    d.  To the pharmacy technician registering, licensing, or
  3 14 disciplinary authorities of other jurisdictions.
  3 15    e.  Pursuant to an order of a court of competent
  3 16 jurisdiction.
  3 17    f.  Pursuant to subsection 11.
  3 18    g.  As otherwise provided by law.
  3 19    5.  An employee or a member of the board, a peer review
  3 20 committee member, a professional pharmaceutical organization
  3 21 committee member, a professional pharmaceutical organization
  3 22 district or local intervenor, or any other person who
  3 23 furnishes information, data, reports, or records in good faith
  3 24 for the purpose of aiding the impaired pharmacist, pharmacist
  3 25 intern, or pharmacy technician, shall be immune from civil
  3 26 liability.  This immunity from civil liability shall be
  3 27 liberally construed to accomplish the purpose of this section
  3 28 and is in addition to other immunity provided by law.
  3 29    6.  An employee or member of the board or a committee or
  3 30 intervenor program is presumed to have acted in good faith.  A
  3 31 person alleging a lack of good faith has the burden of proof
  3 32 on that issue.
  3 33    7.  The board may contract with professional pharmaceutical
  3 34 associations or societies to provide a program for
  3 35 pharmacists, pharmacist interns, and pharmacy technicians who
  4  1 are impaired by chemical abuse, chemical dependence, or mental
  4  2 or physical illness.  Such programs shall include, but not be
  4  3 limited to, education, intervention, and posttreatment
  4  4 monitoring.  A contract with a professional pharmaceutical
  4  5 association or society shall include the following
  4  6 requirements:
  4  7    a.  Periodic reports to the board regarding education,
  4  8 intervention, and treatment activities.
  4  9    b.  Immediate notification to the board's executive
  4 10 secretary or director or the executive secretary's or
  4 11 director's designee of the identity of the pharmacist,
  4 12 pharmacist intern, or pharmacy technician who is participating
  4 13 in a program to aid impaired pharmacists, pharmacist interns,
  4 14 or pharmacy technicians.
  4 15    c.  Release to the board's executive secretary or director
  4 16 or the executive secretary's or director's designee upon
  4 17 written request of all treatment records of a participant.
  4 18    d.  Quarterly reports to the board, by case number,
  4 19 regarding each participant's diagnosis, prognosis, and
  4 20 recommendations for continuing care, treatment, and
  4 21 supervision which maintain the anonymity of the participant.
  4 22    e.  Immediate reporting to the board of the name of an
  4 23 impaired pharmacist, pharmacist intern, or pharmacy technician
  4 24 who the treatment organization believes to be an imminent
  4 25 danger to either the public or to the pharmacist, pharmacist
  4 26 intern, or pharmacy technician.
  4 27    f.  Reporting to the board, as soon as possible, the name
  4 28 of a participant who refuses to cooperate with the program,
  4 29 who refuses to submit to treatment, or whose impairment is not
  4 30 substantially alleviated through intervention and treatment.
  4 31    g.  Immediate reporting to the board of the name of a
  4 32 participant where additional information is evident that known
  4 33 distribution of controlled substances or legend drugs to other
  4 34 individuals has taken place.
  4 35    8.  The board may add a surcharge of not more than ten
  5  1 percent of the applicable fee to a pharmacist license fee,
  5  2 pharmacist license renewal fee, pharmacist intern registration
  5  3 fee, pharmacy technician registration fee, or pharmacy
  5  4 technician registration renewal fee authorized under this
  5  5 chapter to fund programs to aid impaired pharmacists,
  5  6 pharmacist interns, or pharmacy technicians.
  5  7    9.  The board may accept, transfer, and expend funds made
  5  8 available by the federal or state government or by another
  5  9 public or private source to be used in programs authorized by
  5 10 this section.  The board may contract to provide funding on an
  5 11 annual basis to a professional pharmaceutical association or
  5 12 society for expenses incurred in management and operation of a
  5 13 program to aid impaired pharmacists, pharmacist interns, or
  5 14 pharmacy technicians.  Documentation of the use of these funds
  5 15 shall be provided to the board not less than annually for
  5 16 review and comment.
  5 17    10.  Funds and surcharges collected under this section
  5 18 shall be deposited in an account and may be used by the board
  5 19 to administer programs authorized by this section, including
  5 20 the provision of education, intervention, and posttreatment
  5 21 monitoring to an impaired pharmacist, pharmacist intern, or
  5 22 pharmacy technician and to pay the administrative costs
  5 23 incurred by the board in connection with that funding and
  5 24 appropriate oversight, but not for costs incurred for a
  5 25 participant's initial evaluation, referral services,
  5 26 treatment, or rehabilitation subsequent to intervention.
  5 27    11.  The board may disclose that the license of a
  5 28 pharmacist, the registration of a pharmacist intern, or the
  5 29 registration of a pharmacy technician who is the subject of an
  5 30 order of the board that is confidential pursuant to subsection
  5 31 4 is suspended, revoked, canceled, restricted, or retired; or
  5 32 that the pharmacist, pharmacist intern, or pharmacy technician
  5 33 is in any manner otherwise limited in the practice of
  5 34 pharmacy; or other relevant information pertaining to the
  5 35 pharmacist, pharmacist intern, or pharmacy technician which
  6  1 the board deems appropriate.
  6  2    12.  The board may adopt rules necessary for the
  6  3 implementation of this section.
  6  4    Sec. 6.  NEW SECTION.  155A.40  OATHS AND SUBPOENAS –
  6  5 CONTEMPT.
  6  6    1.  The board shall have the power to subpoena witnesses,
  6  7 to compel their appearance, to administer an oath, to examine
  6  8 any person under oath, and to require the production of any
  6  9 documentary or other evidence, whether or not privileged or
  6 10 confidential under law, which is relevant to a matter under
  6 11 investigation by the board and which is needed by the board to
  6 12 determine whether it should commence a disciplinary proceeding
  6 13 against a licensee.
  6 14    2.  Whenever any person subpoenaed pursuant to subsection 1
  6 15 of this section neglects or refuses to obey the terms of such
  6 16 subpoena, to produce documentary or other evidence, or to give
  6 17 testimony, the board may apply to a district court having
  6 18 jurisdiction for the enforcement of a subpoena or the issuance
  6 19 of an order compelling compliance.  The court may sustain the
  6 20 subpoena to the extent that it is found to be in accordance
  6 21 with the law applicable to the issuance of subpoenas or
  6 22 discovery in civil actions.  In proceedings for enforcement,
  6 23 the court may issue an order requiring the appearance of the
  6 24 witness or the production of the evidence or data within a
  6 25 reasonable time under penalty of punishment for contempt in
  6 26 cases of willful failure to comply.
  6 27    Sec. 7.  NEW SECTION.  155A.41  NITROUS OXIDE.
  6 28    1.  UNLAWFUL POSSESSION.  Any person who possesses nitrous
  6 29 oxide or any substance containing nitrous oxide, with the
  6 30 intent to breathe, inhale, or ingest for the purpose of
  6 31 causing a condition of intoxication, elation, euphoria,
  6 32 dizziness, stupefaction, or dulling of the senses, or who
  6 33 knowingly and with the intent to do so is under the influence
  6 34 of nitrous oxide or any material containing nitrous oxide, is
  6 35 guilty of a serious misdemeanor.  This subsection shall not
  7  1 apply to a person who is under the influence of nitrous oxide
  7  2 or any material containing nitrous oxide for the purpose of
  7  3 medical, surgical, or dental care by a person duly licensed to
  7  4 administer such an agent.
  7  5    2.  UNLAWFUL DISTRIBUTION.  Any person who distributes
  7  6 nitrous oxide, or possesses nitrous oxide with intent to
  7  7 distribute to any other person, if such distribution is with
  7  8 the intent to induce unlawful inhaling of the substance or is
  7  9 with the knowledge that the other person will unlawfully
  7 10 inhale the substance, is guilty of a serious misdemeanor.  
  7 11                           EXPLANATION
  7 12    This bill permits qualified individuals who are authorized
  7 13 to administer drugs and who are employed by a home health
  7 14 agency or hospice to obtain, possess, and transport emergency
  7 15 prescription drugs to home care or hospice patients.  The bill
  7 16 also permits more than one emergency drug box in a licensed
  7 17 health care facility in accordance with rules of the board and
  7 18 rules of the department of inspections and appeals.
  7 19 Electronic signatures on prescriptions would be permitted and
  7 20 the purpose of the drug prescribed would be required on
  7 21 prescription drug orders under this bill.  The bill
  7 22 establishes programs to aid impaired pharmacists, pharmacist
  7 23 interns, and pharmacy technicians and provides for reporting,
  7 24 confidentiality, immunity, and funding.  This bill provides
  7 25 for board investigative subpoena power.  The bill also
  7 26 establishes penalties for the unlawful possession and unlawful
  7 27 distribution of nitrous oxide.  Such unlawful possession or
  7 28 distribution shall constitute a serious misdemeanor.  
  7 29 LSB 1321DP 77
  7 30 rn/jj/8.2
     

Text: SSB00170                          Text: SSB00172
Text: SSB00100 - SSB00199               Text: SSB Index
Bills and Amendments: General Index     Bill History: General Index

Return To Home Iowa General Assembly

index Search: Senate Bills and Amendments (77th General Assembly)

© 1997 Cornell College and League of Women Voters of Iowa


Comments about this site or page? webmaster@legis.iowa.gov. Please remember that the person listed above does not vote on bills. Direct all comments concerning legislation to State Legislators.

Last update: Tue Feb 25 03:41:16 CST 1997
URL: /DOCS/GA/77GA/Legislation/SSB/00100/SSB00171/970224.html
jhf